REIMBURSEMENT: Cardiologists, ER Docs Would Suffer Most From 9.9 Percent Cut

Why This Topic Matters

The proposal could affect Medicare payment levels, relative value unit assignments, quality reporting participation, and several operational compliance areas across multiple specialties and practice settings.

Article Sections

1. Overall payment impact and specialty winners and losers

   Summarizes the proposed Medicare physician payment update and the broad specialty groups expected to see larger or smaller changes. It frames the article’s reimbursement focus at a high level.

2. Relative value unit changes and procedure review

   Discusses CMS revisions to work relative value units for selected services and the general mix of increases, decreases, and unchanged values. It also notes that the proposal affects several procedure categories and practice settings.

3. Part B drugs and pricing methodology

   Covers a proposed change in how Medicare calculates payments for Part B drugs and how drug cost reporting would be handled. The section addresses broader drug pricing and reporting policy.

4. Quality reporting initiatives

   Describes new quality measure proposals for the Physician Quality Reporting Initiative and the role of national measure endorsement organizations. It also notes the related reporting incentive timeframe.

5. IVIG

   Explains a temporary Medicare billing approach for intravenous immunoglobulin-related pre-admission services. The section focuses on the continuation of a temporary code-based reimbursement policy.

6. Geographic index

   Reviews CMS updates to the geographic index used in physician practice cost calculations. It also mentions legal and data-related concerns affecting regional reimbursement.

7. Therapy requirements

   Covers proposed therapy-related administrative requirements, including practitioner credentialing standards and plan-of-care timing changes. The section is limited to general therapy compliance and documentation topics.

8. Imaging payment policy

   Summarizes proposed Medicare limits affecting the technical component of imaging services and related settings. It also mentions application of the cap to certain ophthalmologic imaging services.

9. Reporting requirements for anemia-related drugs

   Describes a proposed reporting requirement tied to drugs supplied in the oncology setting for anemia management during anti-cancer treatment. The section focuses on the reporting topic rather than clinical guidance.

10. Compliance and self-referral rules

    Addresses proposed clarifications to physician self-referral and related compliance rules, including concerns about markups for purchased diagnostic tests. The discussion stays at a policy level.

11. E-prescribing

    Covers proposed treatment of computer-generated faxes under electronic prescribing standards. It focuses on the administrative framework for electronic prescribing.